Accessibility Menu
 
Atomo Diagnostics logo

Atomo Diagnostics

(ASX) AT1

Current Price$0.02
Market Cap$21.63M
Since IPO (2020)-93%
5 Year-89%
1 Year+33%
1 Month-29%

Atomo Diagnostics Financials at a Glance

Market Cap

$21.63M

Revenue (TTM)

$8.14M

Net Income (TTM)

$10.43M

EPS (TTM)

$-0.01

P/E Ratio

-4.29

Dividend

$0.00

Beta (Volatility)

0.11 (Low)

Price

$0.02

Volume

2,059,325

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.05

AT1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atomo Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

John Kelly, EMBA

Headquarters

Leichhardt, NSW 2040, AU

AT1 Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-57%

Return on Capital

-66%

Return on Assets

-42%

Earnings Yield

-23.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$21.63M

Shares Outstanding

901.08M

Volume

2.06M

Avg. Volume

2.32M

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$3.81M

EBITDA

$4.69M

Operating Cash Flow

$1.96M

Capital Expenditure

$33.89K

Free Cash Flow

$1.99M

Cash & ST Invst.

$3.22M

Total Debt

$185.10K

Atomo Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.18M

+13.4%

Gross Profit

$1.28M

+44.2%

Gross Margin

-58.55%

N/A

Market Cap

$21.63M

N/A

Market Cap/Employee

$254.42K

N/A

Employees

85

N/A

Net Income

$1.76M

+44.0%

EBITDA

$2.08M

+25.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.76M

-56.5%

Accounts Receivable

$1.86M

+42.1%

Inventory

$1.61M

-11.3%

Long Term Debt

$507.75K

N/A

Short Term Debt

$246.64K

-28.1%

Return on Assets

-41.95%

N/A

Return on Invested Capital

-66.44%

N/A

Free Cash Flow

$1.01M

+46.5%

Operating Cash Flow

$962.50K

+48.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDT.AXIDT Australia Limited
$0.04+0.00%
AGH.AXAlthea Group Holdings Limited
$0.02-4.76%
NTI.AXNeurotech International Limited
$0.01+0.00%
TRU.AXTruScreen Group Limited
$0.02+6.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$63.54+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.47+0.05%
NOKNokia
$12.91+0.04%
INTCIntel
$94.48-0.00%

Questions About AT1

What is the current price of Atomo Diagnostics?

Atomo Diagnostics is trading at A$0.02 per share.

What is the 52-week range for Atomo Diagnostics?

Over the past 52 weeks, Atomo Diagnostics has traded between A$0.01 and A$0.05.

How much debt does Atomo Diagnostics have?

As of the most recent reporting period, Atomo Diagnostics reported total debt of $185,101.

How much cash does Atomo Diagnostics have on hand?

Atomo Diagnostics reported $3.22M in cash and cash equivalents in its most recent financial results.

What is Atomo Diagnostics’s dividend yield?

Atomo Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.